Novel therapies in myeloma: selinexor, venetoclax, among others
Heinz Ludwig et al.
Biomarkers for acute myeloid leukemia (AML) – lessons from IL-2 immunotherapy with HDC
New tools for multiple myeloma treatment monitoring
Bruno Paiva et al.
Multiple myeloma: genomic evolution
Jonathan Keats et al.
Patient and physician perceptions on the symptomatic and economic burden of MPNs